PNC Financial Services Group
BLRX

PNC Financial Services Group’s BioLineRX BLRX Stock Holding History

PNC Financial Services Group’s Portfolio BLRX Stock Details BLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-8
Closed -$1K – 4448
2021
Q3 		$1K Hold
8
– – ﹤0.01% 4176
2021
Q2 		$1K Hold
8
– – ﹤0.01% 4094
2021
Q1 		$1K Buy
+8
New +$962 ﹤0.01% 4013
2016
Q2 		– Sell
-17
Closed -$10K – 4494
2016
Q1 		$10K Hold
17
– – ﹤0.01% 3562
2015
Q4 		$13K Hold
17
– – ﹤0.01% 3493
2015
Q3 		$15K Hold
17
– – ﹤0.01% 3497
2015
Q2 		$27K Hold
17
– – ﹤0.01% 3353
2015
Q1 		$21K Hold
17
– – ﹤0.01% 3480
2014
Q4 		$16K Buy
+17
New +$14.8K ﹤0.01% 3223

Other funds holding BLRX

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GWM
Geneos Wealth Management Englewood, Colorado $4.31B AUM 18.36% 1-Year Est. Return

PNC Financial Services Group's BLRX Position: Q4 2021 in Review

PNC Financial Services Group sold out of BioLineRX (BLRX) in Q4 2021, closing a stake of 8 shares — an estimated $1K sold.

PNC Financial Services Group first reported a position in BLRX in Q4 2014 and held it in 9 quarters. The position peaked at $27K in Q2 2015. 30 funds tracked by Wall St. Rank hold BLRX as of Q4 2021.

  • PNC Financial Services Group reported no remaining BioLineRX position as of Q4 2021 after selling out during the quarter.
  • PNC Financial Services Group sold 8 BioLineRX shares in Q4 2021, an estimated $1K.
  • PNC Financial Services Group first reported a position in BioLineRX in Q4 2014 and held it in 9 quarters.
  • PNC Financial Services Group's BioLineRX position peaked at $27K in Q2 2015.
  • 30 funds tracked by Wall St. Rank held BioLineRX as of Q4 2021.

Based on PNC Financial Services Group's 13F filing for Q4 2021, filed 11 Feb 2022.